Join Dr. Jamie McKenzie to describe the new category of HER2 low breast cancer, discover the new treatment options for patients with HER2 low breast cancer and evaluate antibody drug conjugates.AccreditationsPHYSICIANSACCMEUSF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. USF Health designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Florida Board of MedicineUSF Health is an approved provider of continuing education for physicians through the Florida Board of Medicine. This activity has been reviewed and approved for up to 0.25 continuing education credits. Target Audience: Primary Care Physicians, Internal Medicine Release Date: 5/9/2023Expiration Date: 5/9/2024Relevant Financial Relationships All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.Jamie McKenzie, MD: Nothing to DiscloseClaim CME/CEU Credit for this episode here: https://cmetracker.net/USF/Publisher?page=pubOpen#/getCertificate/355497/qr

Ver todos los episodios